A Bivalent Omicron-Containing Booster Vaccine against Covid-19Spyros Chalkias, Rituparna Das, Bethany Girard et al.|New England Journal of Medicine|2022Cited by 649
Safety and Immunogenicity of XBB.1.5-Containing mRNA VaccinesSpyros Chalkias, Rituparna Das, Nichole McGhee et al.|medRxiv|2023Cited by 79
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim resultsSpyros Chalkias, Rituparna Das, Jordan L. Whatley et al.|Nature Medicine|2023Cited by 77
A Bivalent Omicron-containing Booster Vaccine Against Covid-19Spyros Chalkias, Rituparna Das, Charles Harper et al.|medRxiv|2022Cited by 76
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing VaccinesSpyros Chalkias, Rituparna Das, Nichole McGhee et al.|The Journal of Infectious Diseases|2024Cited by 63